Do you want to read an article? Please log in or register.
Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode
Heart Failure
Related content
Heart Failure
Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline Characteristics
JACC Heart Fail
Kosiborod MN, Cherney D, Connelly K, Desai AS, Guimarães PO, Kuthi L, Lala A, Madrini V Jr, Merkely B, Villota JN, Squire I, Testani JM, Vaclavik J, Verma S, Wranicz J, Dahl M, Eudicone JM, Friberg L, Petrie MC
doi: 10.1016/j.jchf.2024.05.003
RECOMMENDED
Further Publications
Treatment pathways of lipid-lowering therapies in Germany 2016-2022
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Clin Res Cardiol
Katzmann JL, Grellmann C, Leppert B, Müller-Kozarez I, Schulz M, Laufs U
doi: 10.1007/s00392-025-02686-5
Heart Failure
Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry
Eur J Heart Fail
Shahim A, Linde C, Savarese G, Dahlström U, Lund LH, Hage C
doi: 10.1002/ejhf.3565
Cardiac Arrest or Death
Pharmacological Interventions for the Acute Treatment of Hyperkalaemia: A Systematic Review and Meta-analysis
Resuscitation
Jessen MK, Andersen LW, Djakow J, Chong NK, Stankovic N, Staehr C, Vammen L, Petersen AH, Johannsen CM, Eggertsen MA, Mortensen SØ, Høybye M, Nørholt C, Holmberg MJ, Granfeldt A, International Liaison Committee on Resuscitation ILCOR Advanced Paediatric Life Support Task Forces
doi: 10.1016/j.resuscitation.2025.110489
Atrial Fibrillation
Healthcare utilisation and quality of life according to atrial fibrillation burden, episode frequency and duration
Heart
Frausing MHJP, Van De Lande M, Linz D, Crijns HJGM, Tieleman RG, Hemels MEW, De Melis M, Schotten U, Kronborg MB, Nielsen JC, Van Gelder I, Rienstra M
doi: 10.1136/heartjnl-2024-324016
SPECIAL REPORT
Atrial Fibrillation
Considerations When Switching Direct Oral Anticoagulation Therapy in Patients with Non-Valvular Atrial Fibrillation
Further Publications
Sodium Reduction Legislation and Urinary Sodium and Blood Pressure in South Africa
JAMA Cardiol
Gaziano T, Kapaon D, du Toit JD, Crowther NJ, Wade AN, Fabian J, Riumallo-Herl C, Roberts-Toler FC, Gómez-Olivé X, Tollman S
doi: 10.1001/jamacardio.2024.5410
RECOMMENDED
Cardiovascular Risk and Diseases
Long-Term Changes to Cardiovascular Biomarkers After Hormone Therapy in the Women's Health Initiative Hormone Therapy Clinical Trials
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Obstet Gynecol
Nudy M, Aragaki AK, Jiang X, Manson JE, Shadyab AH, Jung SY, Martin LW, Wild RA, Womack C, Mouton CP, Rossouw JE, Schnatz PF
doi: 10.1097/AOG.0000000000005862
Heart Failure
Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure
Eur J Heart Fail
Tomasoni D, Benson L, Gatti P, Villaschi A, Ljungman C, Metra M, Scorza R, Braunschweig F, Melin M, Rosano G, Böhm M, Butler J, Abraham WT, Mullens W, Gadler F, Linde C, Lund LH, Savarese G
doi: 10.1002/ejhf.3719